Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Click to edit Master title style Developing a Cardiac Oncology Fellowship Program ASCO June 2014 Susan Dent Medical Oncologist The Ottawa Hospital Cancer Center Ottawa, Canada The problem Cancer Survivors (Million) 2012 - 2018 Click to edit Master title style 20 15 10 Cancer Survivors (Million) 2012 - 2018 Click to edit Master title style 2 1 0 Click to edit Master title style Brigham, MGH MSK U Penn Medstar Washington Louisville Duke Stanford Vanderbilt MD Anderson Click to edit Master title style Why do we need Cardiac Oncologists? Click to edit Master title style • N = 63 with LVSD (LVEF < / = 45%) post chemo • 67% symptomatic HF: 54% had Cardiology input (black) • Survival 71% vs 41% in no Cardiology input Cardiology input = black No Cardiology = white All = grey Cardiovascular Management of Cancer Patients With Chemotherapy-Associated Left Ventricular Systolic Dysfunction in Real-World Clinical Practice Journal of Cardiac Failure, Volume 19, Issue 9, 2013, 629 - 634 Why do we need cardiac oncologists ? Click to edit Master title style Yoon , Telli , Kao , Matsuda , Carlson , Witteles Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies : Are Clinicians Responding Optimally? Journal of the American College of Cardiology, Volume 56, Issue 20, 2010, 1644 - 1650 What is Needed ! Click to edit Master title style Network / Collaboration • Facilitate networking: ICOS NA , CCON • Create WG and TFs – link • Publicize Cardio-Oncology: websites, social media • Facilitate Research Collaborations: invite participation – group efforts Clinical • Centralize existing resources, create white papers and guidelines • Create a learning pathway Training • Develop a Fellowship program • Standardized Curriculum Fellowship Training – what’s out there Click to edit Master title style • 7 Fellows in US / Canada • No accreditation • No internal funding • No recognized structure to follow Click to edit Master title style Cardiology Oncology Consults Clinics HF Imaging Research Cardiac Oncologist? Click to edit Master title style Should we develop a curriculum for cardiac oncology ? Click toOF GOALS editTHE Master CURRICULUM title style Convey a knowledge base. Stimulate research. Integrate into mainstream cardiology and oncology training programs Reshape the mindset about traditional roles of cardiologists and oncologists . Graduates expand best practices outside the cloistered “cardio oncology centers”, improve practice, lessen disparities in practice. Richard M. Steingart MD Chief, Cardiology Service Memorial Sloan-Kettering Cancer Center Click to edit Master title style cardiac tumors use of chemotherapeutic drugs, biologic products, and growth factors; their mechanisms of action, pharmacokinetics, clinical indications, and limitations, including their effects, toxicity, and interactions Click to edit Master title style Click to edit Master title style Click to edit Master title style Click to Level 1 (Internal edit Master Medicine titleResidents) style • basic knowledge of cancer agents and their potential to cause cardiac damage • Imaging strategies – basic knowledge on cardiac imaging in oncology patients • Basic understanding of treatment strategies for cancer patients experiencing cardiac toxicities Click to Level 2 (Medical/Cardiology edit Master title Resident) style • For residents who wish to broaden their exposure to cardiac oncology patients • More detailed assessment of patients • Intermediate knowledge base • More exposure to advanced cardiac imaging eg. advanced echocardiography (strain/3D) • Understanding of the role of biomarkers in early detection of cardiac toxicity Click to Level 3 (Cardiac edit Master Oncology title Fellow) style • 12-24 months of dedicated fellowship training • advanced knowledge of cancer agents and potential toxicities • broad exposure to in- and out- patients • training in biomarkers, advanced imaging • actively involved in research Level 3 Cardiac Oncology Fellow Click to edit Master title style (12-24 months) • Cardiologist stream • Oncologist stream • • • • • • • • Principles of oncology care Advanced knowledge of cancer agents and potential toxicities Training in biomarkers, advanced cardiac imaging Appropriate cardiac imaging techniques cardiotoxicity surveillancewhen/how long? Evidence based treatment with cardioprotective drugs Actively involved in research • • • • • Understanding cardiac imaging: limitations and common techniques Familiarity with principles of heart failure, arrhythmias and hypertension Familiarity with principles of echocardiography , cardiac MRI and biomarkers Techniques of cardiac surveillance Evidence based treatment with cardioprotective drugs Actively involved in research HOW TO ACCOMPLISH THE ESSENTIAL Click to edit Master title style INSTRUCTION? Cancer therapies taught by cardiologists to cardiology trainees as life saving interventions with manageable toxicity. Longitudinal Outpatient Cardio-Oncology Clinic • Adults currently receiving anthracyclines/trastuzumab. – Continuum of benefit and risk. • Surgical clearance of the cancer patient. • Childhood cancer survivors. • Adults receiving VSPI. – Blood pressure, CHF and ischemia management. Inpatient Consultation Service • Antiplatelet/anticoagulant risks and benefits.